Febrile neutropenia in adjuvant and neoadjuvant chemotherapy for breast cancer: a retrospective study in routine clinical practice from a single institution

被引:0
|
作者
Bacrie, J. [1 ]
Laurans, M. [1 ]
Iorio, P. [1 ]
Fourme, E. [2 ]
Pierga, J. Y. [3 ]
Volters, A. Bethune [1 ]
Benzidane, B. [1 ]
Bozec, L. [3 ]
Lerebours, F. [3 ]
Dubot, C. [3 ]
Bensaoula, O. [3 ]
Lefeuvre, D. [2 ]
机构
[1] Curie Inst, Chemotherapy Outpatient Clin, St Cloud, France
[2] Curie Inst, Dept Stat, St Cloud, France
[3] Curie Inst, Dept Med Oncol, St Cloud, France
关键词
D O I
10.1016/S0959-8049(17)30629-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1824
引用
收藏
页码:S170 / S170
页数:1
相关论文
共 50 条
  • [31] Neoadjuvant chemotherapy in breast cancer in the last 2 decades: Are we improving survival? Retrospective analysis in a single institution
    Ponce, J.
    Delgado, S.
    Ballester, H.
    Martin, T.
    Peiro, G.
    Aranda, F.
    Niveiro, M.
    Montoyo, Y.
    Gomez, N.
    Sanchez, J.
    Rodriguez-Lescure, A.
    Parra, D.
    Gomez, L.
    Lozano, I.
    Massuti, B.
    ANNALS OF ONCOLOGY, 2021, 32 : S51 - S51
  • [32] Is pathological complete response predictable after neoadjuvant chemotherapy in breast cancer? A single institution's retrospective experience
    Winder, Alec A.
    Dijkstra, Birgit
    ANZ JOURNAL OF SURGERY, 2021, 91 (09) : 1779 - 1783
  • [33] Evaluation of Clinical and Pathological Response in Breast Cancer Following Neoadjuvant Chemotherapy- A Single Institution Experience
    Gafoor, Anju Farzana Abdul
    Balakrishnan, Priya
    Krishna, K. M. Jagathnath
    Arjunan, Asha
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (01) : XC1 - XC5
  • [34] Surgical options of the breast and clinical outcomes of breast cancer patients after neoadjuvant chemotherapy: A single-center retrospective study
    Sang, Yuting
    Zhou, Xujie
    Chi, Weiru
    Chen, Jiajian
    Yang, Benlong
    Hao, Shuang
    Huang, Xiaoyan
    Liu, Guangyu
    Shao, Zhimin
    Wu, Jiong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [35] Surgical options of the breast and clinical outcomes in breast cancer patients after neoadjuvant chemotherapy: a single-center retrospective study
    Sang, Yuting
    Chen, Jiajian
    Yang, Benlong
    Hao, Shuang
    Huang, Xiaoyan
    Liu, Guangyu
    Shao, Zhimin
    Wu, Jiong
    CANCER RESEARCH, 2023, 83 (05)
  • [36] Febrile neutropenia and grade 3/4 neutropenia in daily practice of adjuvant chemotherapy for non-small-cell lung cancer
    Marta, Globocnik Kukovica
    Nezka, Hribernik
    Ana, Herzog
    Tanja, Cufer
    ONKOLOGIJA, 2018, 22 (01) : 60 - 66
  • [37] Analysis of Febrile Neutropenia (FN) Rates According to (Neo)adjuvant Breast Cancer Chemotherapy Regimen Use
    Zardawi, S. J.
    Nordman, I.
    Mallesara, G.
    Zdenkowski, N.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 39 - 39
  • [38] Febrile neutropenia in adjuvant docetaxel and cyclophosphamide (TC) with prophylactic pegfilgrastim in patients with breast cancer: A retrospective analysis
    Ngamphaiboon, N.
    Advani, P. P.
    O'Connor, T. L.
    Ademuyiwa, F. O.
    Levine, E. G.
    Riebandt, G.
    Kossoff, E. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [39] Poor response to neoadjuvant chemotherapy of metaplastic breast cancer: a single institution analysis
    Nguyen, L. Thanh
    Phan, T. Khanh
    Pham, G. Hoang
    Phung, H. Thi
    ANNALS OF ONCOLOGY, 2024, 35 : S1362 - S1362
  • [40] Bone loss during neoadjuvant/adjuvant chemotherapy for early stage breast cancer: A retrospective cohort study
    Axelsen, Christian Tang
    Jensen, Anders Bonde
    Jakobsen, Erik Hugger
    Bechmann, Troels
    MOLECULAR AND CLINICAL ONCOLOGY, 2018, 8 (06) : 767 - 772